Loading...
Receive $200 for creating an Interactive Brokers account using our link: Create IBKR account. Read our Interactive Brokers analysis
- Ticker
- EXAS
- Price
- 102.37
- Stock movement down
- -0.11 (-0.11%)
- Company name
- EXACT Sciences Corporation
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Sector
- Healthcare >Diagnostics & Research
- Market cap
- 19.43B
- Ent value
- 22.04B
- Price/Sales
- 6.30
- Price/Book
- 7.77
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- 91.57
- PEG
- -
- EPS growth
- 54.24%
- 1 year return (CAGR)
- 88.67%
- 3 year return (CAGR)
- -
- 5 year return (CAGR)
- -
- 10 year return (CAGR)
- -
Last updated: 2026-01-22
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
DIVIDENDS
EXAS does not pay dividends or no data was received
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | 50.22 |
| Price to FCF | 78.62 |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 6.30 |
| Price to Book | 7.77 |
| EV to Sales | 7.15 |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 189.77M |
| EPS (TTM) | -5.21 |
| FCF per share (TTM) | 1.31 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 3.08B |
| Gross profit (TTM) | 2.08B |
| Operating income (TTM) | -1.00B |
| Net income (TTM) | -986.58M |
| EPS (TTM) | -5.21 |
| EPS (1y forward) | 1.12 |
Margins
Loading...
Margins data
| Gross margin (TTM) | 67.36% |
| Operating margin (TTM) | -32.45% |
| Profit margin (TTM) | -32.01% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 789.04M |
| Net receivables | 306.05M |
| Total current assets | 1.59B |
| Goodwill | 2.37B |
| Intangible assets | 941.20M |
| Property, plant and equipment | 1.40B |
| Total assets | 5.90B |
| Accounts payable | 129.36M |
| Short/Current long term debt | 2.54B |
| Total current liabilities | 584.26M |
| Total liabilities | 3.40B |
| Shareholder's equity | 2.50B |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | 386.81M |
| Capital expenditures (TTM) | 139.73M |
| Free cash flow (TTM) | 247.08M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | -39.44% |
| Return on Assets | -16.72% |
| Return on Invested Capital | -20.28% |
| Cash Return on Invested Capital | 5.08% |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 102.48 |
| Daily high | 102.66 |
| Daily low | 102.30 |
| Daily Volume | 4.36M |
| All-time high | 155.01 |
| 1y analyst estimate | 104.56 |
| Beta | 1.42 |
| EPS (TTM) | -5.21 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 25 Feb 2026 |
Downside potential
Loading...
Downside potential data
| EXAS | S&P500 | |
| Current price drop from All-time high | -33.96% | -0.89% |
| Highest price drop | -74.00% | -19.00% |
| Date of highest drop | 8 Apr 2025 | 8 Apr 2025 |
| Avg drop from high | -60.87% | -2.49% |
| Avg time to new high | - | 6 days |
| Max time to new high | 322 days | 89 days |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
COMPANY DETAILS
Marketcap
19.43B
Marketcap category
Large-cap
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. It offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. The company also provides Oncotype DX Breast Recurrence Score Test; Oncotype DX Breast DCIS Score Test; Oncotype DX Colon Recurrence Score Test; OncoExTra Test for tumor profiling for patients with advanced, metastatic, refractory, relapsed, or recurrent cancer; and Riskguard Test, a hereditary cancer test to understand their inherited risk of cancer. Its pipeline focus on advancing screening and diagnostic products, including risk assessment, screening and prevention, early disease diagnosis, adjuvant and/or neoadjuvant disease treatment, metastatic disease treatment selection, and recurrence monitoring. The company has license agreements with MAYO Foundation for Medical Education and Research and Johns Hopkins University. Exact Sciences Corporation was incorporated in 1995 and is headquartered in Madison, Wisconsin.
Employees
6900
Investor relations
-
SEC filings
CEO
Kevin T. Conroy
Country
USA
City
Madison
Stock type
Common stock
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
iO Charts is a Seeking Alpha partnerNext page